Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge
Newletter
Events

Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge
Newletter
Events

Tag: #Global Trends

AI-Driven Drug Discovery & Computational Oncology: Boehringer Ingelheim Licenses Owkin’s ‘K Pro’ AI Engine and Multimodal Biological Datasets to Accelerate Target Identification in Cancer and Immunology

03/09/2026 Published by Pharma Biz

Key Development On September 2, 2026, biomedical artificial intelligence innovator Owkin, Inc. entered into a strategic licensing and research partnership... Read more

Category: Uncategorized

Tags: #Global Trends

Biopharmaceutical Manufacturing Recovery & Incretin Strategy: Aspen Pharmacare Projects FY27 Normalized EBITDA of at Least 9 Billion Rand ($561 Million) – Accelerating Generic Semaglutide Expansion Across Emerging Markets Alongside Exclusive Mounjaro Commercialization

03/09/2026 Published by Pharma Biz

Key Development On September 2, 2026, South Africa-based pharmaceutical leader Aspen Pharmacare Holdings Ltd. (JSE: APN) issued financial guidance for... Read more

Category: Uncategorized

Tags: #Global Trends

Pediatric Nutrition & Biomanufacturing Infrastructure: Nestlé Commits $393 Million (2 Billion Reais) to Brazil Nutrition & Health Division – Constructing New Infant Formula Plant in Minas Gerais to Localize Supply and Anchor Latin American Exports

03/09/2026 Published by Pharma Biz

Key Development On September 3, 2026, global nutrition and health science leader Nestlé S.A. (SIX: NESN) announced a 2 billion... Read more

Category: Uncategorized

Tags: #Global Trends

Tobacco Regulatory Litigation & Administrative Law: Altria Sues US FDA in Federal Court Demanding Complete Overhaul of Premarket Tobacco Application (PMTA) Framework – Citing Statutory 180-Day Deadlines and Market Distortions Across the $22 Billion Sector

03/09/2026 Published by Pharma Biz

Key Development On September 2, 2026, Altria Group, Inc. (NYSE: MO)—the manufacturer of Marlboro cigarettes in the United States—alongside two... Read more

Category: Uncategorized

Tags: #Global Trends

Cell Therapy Safety & Translational Immunology: Novartis and Bristol Myers Squibb Pause Autoimmune CAR-T Trials Following Three Fatal IEC-HS Cases – Scrutinizing Hyper-Proliferation Risks in Rapid-Manufacturing Platforms

03/09/2026 Published by Pharma Biz

Key Development In early September 2026, biopharmaceutical leaders Novartis AG (SIX: NOVN / NYSE: NVS) and Bristol Myers Squibb (NYSE:... Read more

Category: Uncategorized

Tags: #Global Trends

Biomanufacturing Decentralization & Personalized Medicine: ARPA-H Commits $125 Million to Fund GIVE Program – Accelerating Automated, Point-of-Care RNA Drug Production and 24-Hour Quality Control Lot Release

03/09/2026 Published by Pharma Biz

Key Development On September 2, 2026, the Advanced Research Projects Agency for Health (ARPA-H), an agency operating within the U.S.... Read more

Category: Uncategorized

Tags: #Global Trends

Biomanufacturing Footprint & Industrial Rationalization: Novartis Signals 130 Redundancies in Switzerland Amid Biologics Realignment, Relocating Laboratories to Main Basel Campus while Divesting Small-Scale Manufacturing

03/09/2026 Published by Pharma Biz

Key Development On September 2, 2026, Swiss multinational pharmaceutical leader Novartis AG (SIX: NOVN / NYSE: NVS) announced a structural... Read more

Category: Uncategorized

Tags: #Global Trends

TREELINE–ROCHE COMBINATION STRATEGY PUTS BCL6 DEGRADATION AT THE CENTER OF NEXT-GENERATION LYMPHOMA THERAPY

03/09/2026 Published by HealthBiz

Key Development Treeline Biosciences has entered a clinical trial collaboration and drug-supply agreement with Roche to evaluate its investigational BCL6... Read more

Category: Uncategorized

Tags: #Global Trends

Precision Oncology & Molecular Therapeutics: US FDA Clears Revolution Medicines’ Rasonque® (Daraxonrasib) for Metastatic Pancreatic Ductal Adenocarcinoma – Doubling Median Overall Survival to 13.2 Months with $477,600 Annual WAC Pricing

03/09/2026 Published by Pharma Biz

Key Development On August 26, 2026, the U.S. Food and Drug Administration (FDA) approved Rasonque® (daraxonrasib), an oral small-molecule therapeutic... Read more

Category: Uncategorized

Tags: #Global Trends

Posts pagination

Previous page Page 1 … Page 13 Page 14 Page 15 … Page 104 Next page

Facebook

Map

Workday: Monday to Friday
Working hours: 8am to 5pm
Address: 8th floor, Hyco 4 building, 205A Nguyen Xi Street, Binh Thanh Ward, HCMC

Please enable JavaScript in your browser to complete this form.

Email

Email *

Get Your Weekly Market Insights Stay informed on Vietnam's market & Healthcare Alliance updates

Online Members

Recent Comments

GauTruc on New Biotech Startup Secures $125 Million to Advance Pain Medication

HEALTHCARE INSIGHTS

All rights reserved